| Product Code: ETC6010320 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Afghanistan Irritable Bowel Syndrome (IBS) Market Overview |
3.1 Afghanistan Country Macro Economic Indicators |
3.2 Afghanistan Irritable Bowel Syndrome (IBS) Market Revenues & Volume, 2021 & 2031F |
3.3 Afghanistan Irritable Bowel Syndrome (IBS) Market - Industry Life Cycle |
3.4 Afghanistan Irritable Bowel Syndrome (IBS) Market - Porter's Five Forces |
3.5 Afghanistan Irritable Bowel Syndrome (IBS) Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.6 Afghanistan Irritable Bowel Syndrome (IBS) Market Revenues & Volume Share, By Medical Condition, 2021 & 2031F |
3.7 Afghanistan Irritable Bowel Syndrome (IBS) Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.8 Afghanistan Irritable Bowel Syndrome (IBS) Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
4 Afghanistan Irritable Bowel Syndrome (IBS) Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about irritable bowel syndrome (IBS) among the population |
4.2.2 Growing prevalence of IBS in Afghanistan |
4.2.3 Rising demand for effective IBS treatments and medications |
4.3 Market Restraints |
4.3.1 Limited access to healthcare facilities and specialized treatment for IBS in remote areas of Afghanistan |
4.3.2 High cost associated with IBS diagnosis, treatment, and medication |
4.3.3 Cultural barriers and stigma surrounding digestive health issues in Afghanistan |
5 Afghanistan Irritable Bowel Syndrome (IBS) Market Trends |
6 Afghanistan Irritable Bowel Syndrome (IBS) Market, By Types |
6.1 Afghanistan Irritable Bowel Syndrome (IBS) Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 Afghanistan Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Drug Type, 2021- 2031F |
6.1.3 Afghanistan Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Lubiprostone, 2021- 2031F |
6.1.4 Afghanistan Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Linaclotide, 2021- 2031F |
6.1.5 Afghanistan Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Eluxadoline, 2021- 2031F |
6.1.6 Afghanistan Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Rifaximin, 2021- 2031F |
6.1.7 Afghanistan Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Alosetron, 2021- 2031F |
6.1.8 Afghanistan Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Afghanistan Irritable Bowel Syndrome (IBS) Market, By Medical Condition |
6.2.1 Overview and Analysis |
6.2.2 Afghanistan Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By IBS-Constipation, 2021- 2031F |
6.2.3 Afghanistan Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By IBS-diarrhea, 2021- 2031F |
6.2.4 Afghanistan Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Mixed, 2021- 2031F |
6.3 Afghanistan Irritable Bowel Syndrome (IBS) Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Afghanistan Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.3.3 Afghanistan Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.3.4 Afghanistan Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.4 Afghanistan Irritable Bowel Syndrome (IBS) Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 Afghanistan Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Afghanistan Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Clinics, 2021- 2031F |
6.4.4 Afghanistan Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Homecare Settings, 2021- 2031F |
7 Afghanistan Irritable Bowel Syndrome (IBS) Market Import-Export Trade Statistics |
7.1 Afghanistan Irritable Bowel Syndrome (IBS) Market Export to Major Countries |
7.2 Afghanistan Irritable Bowel Syndrome (IBS) Market Imports from Major Countries |
8 Afghanistan Irritable Bowel Syndrome (IBS) Market Key Performance Indicators |
8.1 Number of healthcare facilities offering IBS diagnosis and treatment services in Afghanistan |
8.2 Percentage increase in IBS diagnosis rates annually |
8.3 Patient satisfaction scores with IBS treatment and management programs |
8.4 Adoption rate of new IBS medications or therapies in the market |
8.5 Number of healthcare professionals specializing in gastroenterology and IBS treatment in Afghanistan |
9 Afghanistan Irritable Bowel Syndrome (IBS) Market - Opportunity Assessment |
9.1 Afghanistan Irritable Bowel Syndrome (IBS) Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.2 Afghanistan Irritable Bowel Syndrome (IBS) Market Opportunity Assessment, By Medical Condition, 2021 & 2031F |
9.3 Afghanistan Irritable Bowel Syndrome (IBS) Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.4 Afghanistan Irritable Bowel Syndrome (IBS) Market Opportunity Assessment, By End-Users, 2021 & 2031F |
10 Afghanistan Irritable Bowel Syndrome (IBS) Market - Competitive Landscape |
10.1 Afghanistan Irritable Bowel Syndrome (IBS) Market Revenue Share, By Companies, 2024 |
10.2 Afghanistan Irritable Bowel Syndrome (IBS) Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here